Mid-Eastern Chapter 47th Annual Meeting: Nuclear Medicine and Molecular Imaging Update CME / CPD
Full Course: 15.5 AMA PRA Category 1 Credits™ for CME / CEU / CPD; (EXPIRES 5/14/20)
Course(s) are appropriate for: Radiologists, Physicians, Subspecialist Physicians
Series 47 (NMMI47) Topics Include: Evolving Role of PET, Cardic CT and MRI, PET Imaging in Prostate Cancer, Unusual Imaging Studies, PET/CT Coding and Billing, and more.
To view topic outline of the full course, see below:
Full Course:
NMMI47
Full Course Price:
$735
Format:
Available in DVD-ROM format.
Topics
Neuro, Head and Neck
The Evolving Role of PET/CT for Neuroendocrine Tumor Imaging; PET Imaging of Alzheimer's and Dementia; Diagnosis & Therapy of Hyperthyroidism With Emphasis on Graves Disease; Thyroid Maliganacy and the ATA guidelines; and Thyroid Cancer Guidelines: A Nuclear Medicine Physician's Case Based Review
Nuclear Cardiovascular Imaging
Best Practice Cardiac PET in 2017; F-18 FDG PET/CT Imaging in Cardiac Sarcoidosis: What's Hot!; Cardiac CT and MRI - State of the Art; and MIBG Imaging in Heart Failure Management
Body Imaging
Integrating MRI and PSMA PET Imaging in Prostate Cancer; Hepatobiliary Scintigraphy in Chronic Abdominal Pain; Glucose Metabolism Changes in Patients With Sepsis on FDG PET; and The Role of 18F-FDG PET/CT in the Management of Gastric Cancers
Perspectives and Procedures
18F-FDG-PET Imaging's Contributions to Medicine; SNMMI Background and Agenda; and Unusual Imaging Studies
Practice Improvements
The Importance of Advocacy to the Nuclear Medicine Professional; PET/CT Coding and Billing: - Am I Coding it Correctly?; and Emergency Preparedness
Course Objective
Following this continuing medical education activity, the participant should be able to:
1. Discuss the importance of Partial Volume Effect (PVE) in designing and testing new radiotracers for both research and clinical applications.
2. Describe the various PET radiopharmaceuticals that play a role in thyroid imaging.
3. Compare Nuclear Medicine diagnostic outcomes with radiographic and/or other diagnostic procedures.
4. Utilize Cardiac PET to optimal laboratory performance.
5. Describe the role and limitations of PSMA PET-CT.
6. Discuss the uses of [F18]-fluorodeoxyglucose in patients with cognitive decline/dementia.
Accreditation
Release Date: 5/15/17 CME Expiration: 5/14/20
This enduring material has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Education Group (Global) and Meetings By Mail. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All credits for this enduring material are applicable toward Self Assessment CME requirements for Maintenance of Certification (MOC).
Mid-Eastern Chapter 47th Annual Meeting: Nuclear Medicine and Molecular Imaging Update CME / CPD
Full Course: 15.5 AMA PRA Category 1 Credits™ for CME / CEU / CPD; (EXPIRES 5/14/20)
Course(s) are appropriate for: Radiologists, Physicians, Subspecialist Physicians
Series 47 (NMMI47) Topics Include: Evolving Role of PET, Cardic CT and MRI, PET Imaging in Prostate Cancer, Unusual Imaging Studies, PET/CT Coding and Billing, and more.
To view topic outline of the full course, see below:
Topics
Neuro, Head and Neck
The Evolving Role of PET/CT for Neuroendocrine Tumor Imaging; PET Imaging of Alzheimer's and Dementia; Diagnosis & Therapy of Hyperthyroidism With Emphasis on Graves Disease; Thyroid Maliganacy and the ATA guidelines; and Thyroid Cancer Guidelines: A Nuclear Medicine Physician's Case Based Review
Nuclear Cardiovascular Imaging
Best Practice Cardiac PET in 2017; F-18 FDG PET/CT Imaging in Cardiac Sarcoidosis: What's Hot!; Cardiac CT and MRI - State of the Art; and MIBG Imaging in Heart Failure Management
Body Imaging
Integrating MRI and PSMA PET Imaging in Prostate Cancer; Hepatobiliary Scintigraphy in Chronic Abdominal Pain; Glucose Metabolism Changes in Patients With Sepsis on FDG PET; and The Role of 18F-FDG PET/CT in the Management of Gastric Cancers
Perspectives and Procedures
18F-FDG-PET Imaging's Contributions to Medicine; SNMMI Background and Agenda; and Unusual Imaging Studies
Practice Improvements
The Importance of Advocacy to the Nuclear Medicine Professional; PET/CT Coding and Billing: - Am I Coding it Correctly?; and Emergency Preparedness
Course Objective
Following this continuing medical education activity, the participant should be able to:
1. Discuss the importance of Partial Volume Effect (PVE) in designing and testing new radiotracers for both research and clinical applications.
2. Describe the various PET radiopharmaceuticals that play a role in thyroid imaging.
3. Compare Nuclear Medicine diagnostic outcomes with radiographic and/or other diagnostic procedures.
4. Utilize Cardiac PET to optimal laboratory performance.
5. Describe the role and limitations of PSMA PET-CT.
6. Discuss the uses of [F18]-fluorodeoxyglucose in patients with cognitive decline/dementia.
Accreditation
Release Date: 5/15/17
CME Expiration: 5/14/20
This enduring material has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Education Group (Global) and Meetings By Mail. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All credits for this enduring material are applicable toward Self Assessment CME requirements for Maintenance of Certification (MOC).